Mycobacterium fortuitum endocarditis associated with cardiac surgery, Serbia

Emerging Infectious Diseases

Volumn 19, Issue 3, 2013, Pages 517-519

  Vuković, Dragana ^a   Parezanović, Vojislav ^a,b   Savić, Branislava ^a   Dakić, Ivana ^a   Laban Nestorović, Suzana ^b   Ilić, Slobodan ^a,b   Ćirković, Ivana ^a   Stepanović, Srdjan ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFTRIAXONE; CIPROFLOXACIN; IMIPENEM; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL ENDOCARDITIS; CASE REPORT; CHILD; FATIGUE; FEMALE; FEVER; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; LETTER; MALE; MYCOBACTERIUM FORTUITUM; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SERBIA; TRANSTHORACIC ECHOCARDIOGRAPHY;

ANIMALS; ANTI-BACTERIAL AGENTS; CARDIAC SURGICAL PROCEDURES; CATTLE; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ENDOCARDITIS, BACTERIAL; FEMALE; GENOTYPE; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; INFANT, NEWBORN; MALE; MYCOBACTERIUM FORTUITUM; PERICARDIUM; REOPERATION; TREATMENT OUTCOME;

EID: 84874262462     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1903.120763     Document Type: Letter

References (10)

1. Griffith DE, Aksamit T, Brown-Elliot BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416. Erratum in: Am J Respir Crit Care Med. 2007;175:744-5. http://dx.doi.org/10.1164/rccm.200604-571ST
2. Spell DW, Szurgot JG, Greer RW, Brown JW. Native valve endocarditis due to Mycobacterium fortuitum biovar fortuitum: case report and review. Clin Infect Dis. 2000;30:605-6. http://dx.doi.org/10.1086/313695
3. Kunin M, Salamon F, Weinberger M, Genkin I, Sagie A, Tur-Kaspa R. Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum. Eur J Clin Microbiol Infect Dis. 2002;21:539-41. http://dx.doi.org/10.1007/s10096-002-0763-8
4. Olalla J, Pombo M, Aguado JM, Rodríguez E, Palenque E, Costa JR, et al. Mycobacterium fortuitum complex endocarditis-case report and literature review. Clin Microbiol Infect. 2002;8:125-9. http://dx.doi.org/10.1046/j.1198-743x.2001.00397.x
5. Richter E, Rüsch-Gerdes S, Hillemann D. Evaluation of the GenoType Mycobacterium assay for identification of mycobacterial species from cultures. J Clin Microbiol. 2006;44:1769-75. http://dx.doi.org/10.1128/JCM.44.5.1769-1775.2006
6. Sampaio JL, Chimara E, Ferrazoli L, da Silva Telles MA, Del Guercio VM, Jerico ZV, et al. Application of four molecular typing methods for analysis of Mycobacterium fortuitum group strains causing post-mammaplasty infections. Clin Microbiol Infect. 2006;12:142-9. http://dx.doi.org/10.1111/j.1469-0691.2005.01312.x
7. Sharma S, Tleyjeh IM, Espinosa RE, Costello BA, Baddour LM. Pacemaker infection due to Mycobacterium fortuitum. Scand J Infect Dis. 2005;37:66-7. http://dx.doi.org/10.1080/00365540410020910
8. Strabelli TMV, Siciliano RF, Castelli JB, Demarchi LM, Leão SC, Viana-Niero C, et al. Mycobacterium chelonae valve endocarditis resulting from contaminated biological prostheses. J Infect. 2010;60:467-73. http://dx.doi.org/10.1016/j.jinf.2010.03.008
9. Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol. 1998;52:453-90. http://dx.doi.org/10.1146/annurev.micro.52.1.453
10. Wright RC. The sterilizing capacity of propylene oxide and chlorhexidine diacetate solutions upon pre-injection swabs saturated with propan-2-ol. J Hyg (Lond) 1983;91:287-92. http://dx.doi.org/10.1017/S0022172400060307